Reproductive Depression and the Response to Hormone Therapy

1Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Many cases of depression in women are due to endocrine factors and inappropriate treatment by antidepressants or mood-stabilizing drugs such as lithium. The syndrome reproductive depression includes premenstrual depression (PMDD), postnatal depression (PND) and climacteric depression which is more severe in the transitional phase 2 or 3 years before the periods cease rather than in the years after the menopause. Such patients are usually free of depression during pregnancy. The diagnosis cannot be made by measuring hormone levels but by a careful history relating depression to monthly cycles and the postnatal state. The range and aetiology of depression in women is different than in men and cannot be understood without knowledge of the effect that oestrogen, progesterone and androgens have upon mood. These frequent problems are usually treated badly by psychiatrists who have little knowledge and less interest in the effect of hormones on mood. Treatment should be by oestrogens preferably by the transdermal route possibly with the addition of testosterone and if necessary the addition of progesterone to protect the endometrium.

Cite

CITATION STYLE

APA

Studd, J. W., Savvas, M., & Watson, N. (2019). Reproductive Depression and the Response to Hormone Therapy. In International Society of Gynecological Endocrinology Series (pp. 125–133). Springer Nature. https://doi.org/10.1007/978-3-030-11355-1_8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free